P450C17 (CYP17) deficiency in native Mexican patient with a novel CYP17A1 mutation

Endocrine Practice

Volumn 17, Issue 1, 2011, Pages 99-103

  Durán Pérez, Edgar G ^a   González Del Rincón, Lourdes ^a   Moreno Loza, Oscar T ^a   Martín De Saro, Monica D ^a   Segovia Palomo, Antonio ^a   Sánchez Pedraza, Valentín ^a   Kofman Alfaro, Susana ^a   Queipo García, Gloria E ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 17; CYTOCHROME P450 17A1; DEOXYCORTICOSTERONE; HYDROXYPROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST DEVELOPMENT; CASE REPORT; CLINICAL ASSESSMENT; CONGENITAL ADRENAL HYPERPLASIA; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; KARYOTYPE; LAPAROTOMY; MENARCHE; METABOLIC ALKALOSIS; MOLECULAR GENETICS; MUSCLE WEAKNESS; RADIODIAGNOSIS;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; FEMALE; HUMANS; KARYOTYPING; MUTATION; STEROID 17-ALPHA-HYDROXYLASE;

EID: 79952403162     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP10135.CR     Document Type: Article

References (14)

1. Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am. 2001;30:101-119. (Pubitemid 32381716)
2. Rosa F, Duff M, Meyer M, et al. P450c17 deficiency: Clinical and molecular characterization of six patients. J Clin Endocrinol Metab. 2007;92:1000-1007. (Pubitemid 46465675)
3. Mohaupt MG. The role of adrenal steroidogenesis in arterial hypertension. Endocr Rev. 2008;13:133-144.
4. Achermann JC, Hughes IA. Disorders of sex development. In: Kronemberg HM, Melmed S, Polonsky KS, Larsen PR. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders Elsevier, 2008: 816-818.
5. New MI. Male pseudohermaphroditism due to 17 alphahydroxylase deficiency. J Clin Invest. 1970;49:1930-1941.
6. Stewart PM. Congenital adrenal hyperplasia. In Kronemberg HM, Melmed S, Polonsky KS, PR Larsen. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders Elsevier, 2008: 485-494.
7. Martin RM, Lin CH, Costa EM, et al. P450c17 deficiency in Brazilian patients: Biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping. J Clin Endocrinol Metab. 2003;88:5739-5746. (Pubitemid 38033044)
8. Ghayee HK, Auchus RJ. Basic concepts and recent developments in human steroid hormone biosynthesis. Rev Endocr Metab Disord. 2007;8:289-300.
9. Van Der Akker EL, Koper JW, Boehmer AL, et al. Differential inhibition of 17alpha-hydroxilase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency. J Clin Endocrinol Metab. 2002;87:5714-5721. (Pubitemid 36034381)
10. Yanase T, Simpson ER, Waterman MR. 17 alphahydroxylase/ 17,20-lyase deficiency: From clinical investigation to molecular definition. Endocr Rev. 1991;12:91-108.
11. Durán-Pérez EG, González RML, Moreno-Loza OT, et al. Desordenes de la diferenciación sexual por mutaciones en CYP17. Rev Endocrinol Nutr. 2009; 17:153-160.
12. Hughes IA, Houk C, Ahmed SF, Lee PA; Lawson Wilkins Pediatric Society/European Society for Paediatric Endocrinology Consensus Group. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006;2:148-162.
13. Nájera N, Garibay N, Pastrana Y, et al. Loss of cytochrome P450 17A1 protein expression in a 17alphahydroxylase/ 17,20-lyase-deficient 46,XY female caused by two novel mutations in the CYP17A1 gene. Endocr Pathol. 2009;20:249-255.
14. Consortium on the Management of Disorders of Sex Differentiation. Clinical guidelines for the management of disorders of sex development in childhood. Intersex Society of North American. 2006. Available at: http://www.dsdguidelines.org.